Connect with us

Technology

Peptide Synthesis Market: USD 2.59 Billion by 2031, Driven by Therapeutic Demand & Advanced Synthesis Technologies, Says Mordor Intelligence

Published

3 months ago

on

HYDERABAD, India, Aug. 18, 2026 /PRNewswire/ — According to the latest report by Mordor Intelligence, the peptide synthesis market size is estimated at USD 1.90 billion in 2026 and is projected to reach USD 2.59 billion by 2031, registering a CAGR of 6.39% during the forecast period (2026–2031). Market expansion is being driven by growing demand for peptide-based therapeutics, increasing pharmaceutical and biotechnology research activities, and continued advancements in peptide synthesis technologies that support drug discovery and commercial manufacturing. 

The peptide synthesis market continues to evolve as pharmaceutical and biotechnology companies expand investments in peptide-based drug development across chronic disease, oncology, metabolic disorders, and rare disease applications. Increasing clinical research activity and the growing pipeline of peptide therapeutics are strengthening demand for high-quality synthesis platforms, specialized reagents, and contract manufacturing capabilities. 

Solid-phase peptide synthesis continues to serve as a widely utilized production approach, while emerging enzymatic and cell-free synthesis methods are gaining attention for their ability to improve sustainability and reduce solvent consumption during manufacturing processes. 

Technological advancements are reshaping the competitive landscape. Automation, high-throughput synthesizers, advanced purification systems, and greener chemistry approaches are improving manufacturing efficiency while supporting increasingly complex peptide production. Artificial intelligence-assisted peptide design and expanded contract development and manufacturing capabilities are also contributing to faster research workflows and broader commercial opportunities across the industry. 

Peptide Synthesis Market Share by Region 

North America represents a significant share of the peptide synthesis market, supported by advanced pharmaceutical research infrastructure, strong biotechnology investment, and increasing development of peptide-based therapeutics. 

Europe holds a notable position in the market, driven by growing pharmaceutical innovation, increasing adoption of sustainable manufacturing approaches, and continued investment in life sciences research. 

Asia-Pacific is emerging as the fastest-growing region due to expanding pharmaceutical manufacturing capabilities, rising biotechnology investments, and increasing contract manufacturing activity across countries including China, India, Japan, and South Korea. 

Soumya Goud, Senior Research Manager, Mordor Intelligence, says, “The peptide synthesis market reflects sustained innovation across therapeutic development and manufacturing technologies. Mordor Intelligence applies structured research methodologies supported by cross-validated industry data and transparent analytical frameworks, providing decision-makers with balanced and dependable market intelligence.” 

Peptide Synthesis Market Trends & Forecast 

Growing Adoption of Advanced Peptide Manufacturing Technologies 

Pharmaceutical companies are increasingly utilizing automated synthesis platforms and advanced purification technologies to improve production efficiency, product quality, and manufacturing scalability. 

Rising Demand for Contract Manufacturing and Development Services 

Growing outsourcing across pharmaceutical and biotechnology companies is creating increased demand for specialized peptide synthesis services, GMP manufacturing capabilities, and scalable production solutions. 

Increasing Focus on Sustainable Peptide Synthesis 

Manufacturers are exploring greener chemistry approaches, enzymatic synthesis methods, and reduced-solvent manufacturing processes to improve sustainability while maintaining production quality. 

Peptide Synthesis Market Segmentation Overview 

By Technique

Solid-PhaseManual SPPS  Automated SPPS  Microwave-Assisted SPPS  Liquid-Phase  Batch LPPS  Continuous-Flow LPPS  Hybrid & Recombinant  Cell-Free/Enzymatic  

By Product Type  

Equipment  Peptide Synthesizers  Cleavage & Deprotection Systems  Purification (Prep-HPLC)  Lyophilizers  Reagents & Consumables  Amino-Acid Building Blocks  Resins  Coupling Reagents & Activators  Solvents  Enzymes  Other Reagents & Consumables  Services  Custom/Catalog Peptide Synthesis  GMP Peptide Manufacturing  Peptide Library Design  Post-translational Modification Services  

By End User  

Pharmaceutical & Biotechnology Companies  Peptide CDMOs & CROs  Academic & Research Institutes  Diagnostic Laboratories  Food & Nutraceutical Producers  Cosmetic Manufacturers  

By Geography  

North America  United States  Canada  Mexico  Europe  Germany  United Kingdom  France  Italy  Spain  Rest of Europe  Asia-Pacific  China  India  Japan  Australia  South Korea  Rest of Asia-Pacific  Middle East and Africa  GCC  South Africa  Turkey Rest of Middle East and Africa  South America  Brazil  Argentina   Rest of South America  

For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/peptide-synthesis-market?utm_source=prnewswire 

Peptide Synthesis Market Competitive Outlook 

The peptide synthesis market features specialized peptide manufacturers, pharmaceutical suppliers, life sciences companies, and contract manufacturing organizations focused on expanding production capabilities and improving manufacturing efficiency. Market participants are investing in automated synthesis technologies, advanced purification platforms, sustainable manufacturing approaches, and GMP-compliant production facilities to strengthen their competitive positions. 

Strategic capacity expansions, technology innovation, and growing partnerships across pharmaceutical research and commercial manufacturing continue to shape the competitive landscape as peptide-based therapeutics gain broader adoption. 

Major Companies in the Peptide Synthesis Market include: 

Merck KGaA Thermo Fisher Scientific Inc. GenScript Bachem Holding AG Biotage AB 

Check out related reports published by Mordor Intelligence: 

Consumer Genomics Market 
The consumer genomics market is estimated to grow from USD 2.96 billion in 2026 to USD 8.66 billion by 2031, registering a CAGR of 23.95% during the forecast period. Growth is supported by increasing consumer interest in personalized health insights, expanding availability of direct-to-consumer genetic testing, and growing awareness of genomics-based wellness and ancestry applications. 

Immune Repertoire Sequencing Market 
The immune repertoire sequencing market is projected to grow from USD 358.41 million in 2026 to USD 560.36 million by 2031, advancing at a CAGR of 9.35% during the forecast period. Market expansion is supported by increasing applications in immunology research, growing demand for advanced immune profiling, and the expanding use of sequencing technologies in therapeutic and diagnostic research. 

Medical Biomimetic Materials Market 
The medical biomimetic materials market is expected to increase from USD 20.66 billion in 2026 to USD 29.33 billion by 2031, registering a CAGR of 7.26% during the forecast period. Growth is driven by increasing demand for advanced materials that replicate biological structures and functions, alongside their expanding applications in tissue engineering, regenerative medicine, and medical devices. 

Know more about Mordor Intelligence:   

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.   

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.  

For any inquiries, please contact: 
media@mordorintelligence.com
https://www.mordorintelligence.com/contact-us 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/peptide-synthesis-market-usd-2-59-billion-by-2031–driven-by-therapeutic-demand–advanced-synthesis-technologies-says-mordor-intelligence-302853965.html

SOURCE Mordor Intelligence Private Limited

Related Topics:
Continue Reading

Technology

The First Cartridge-Free Smart Waterless Diffuser Is Here. What Would You Fill It With?

Published

45 minutes ago

on

November 14, 2026

By

Lephrone set out to solve a frustration for customers who want smart control over their home fragrance and the freedom to choose their own oils. The H300 is the first waterless diffuser to combine cartridge-free refills, Wi-Fi app control, smart home integration, and an in-app fragrance oil library with scanning and personal notes. Customers can use their favorite compatible oils, create their own blends, and use the app to set a scenting schedule and track how much oil is left.

NEW YORK, Nov. 14, 2026 /PRNewswire-PRWeb/ — “There are thousands of fragrance oils out there, so why lock yourself into just one brand?” said a Lephrone developer.

“Lephrone took the best of the diffuser world and left the worst behind.”

We wanted to make a device for people who need a ritual to unwind and want more control over their surroundings. There’s a whole world of sensory experiences out there, and our goal was to bring the way you manage scent at home into the digital world.

With the H300 lephrone diffuser, we kept what we liked about smart cartridge-based diffusers: Wi-Fi connectivity, lephrone app, voice control, and the ability to recognize oils and track how much is left. We made sure it supports both 2.4 GHz and 5 GHz Wi-Fi. We also did away with what frustrated us most: never-ending subscriptions, cartridges that run out too quickly, and limits on which oils you can use. With the H300, you get to choose the oils you want and create blends you love.

We also added support for multiple users and multiple diffusers, so everyone in the household can control the devices and set schedules. The H300 can run even when it’s offline.

We’re releasing our own fragrances, too. In the app, you can scan them into your personal fragrance library and write down how a scent made you feel, whether you liked it, and what others at home thought of it. That matters because after trying a few oils, it’s easy to forget which one you loved most or which one everyone else kept asking for.

We’re rolling this out to more Lephrone models next. Stay tuned.

Media Contact

Elina, Lephrone, 1 6463844148, info@lephrone.com, Lephrone

View original content to download multimedia:https://www.prweb.com/releases/the-first-cartridge-free-smart-waterless-diffuser-is-here-what-would-you-fill-it-with-302939367.html

SOURCE Lephrone

Continue Reading

Technology

HONGQI EHS4 Set for Global Debut in Venice: Eastern Elegance Arrives in Europe

Published

2 hours ago

on

November 14, 2026

By

VENICE, Italy, Nov. 15, 2026 /PRNewswire/ — HONGQI, one of China’s leading automotive marques, will introduce its all-new all-electric SUV, HONGQI EHS4, to the European market. Making its global debut in Venice, Italy, on 16 November 2026, the EHS4 marks another milestone in the brand’s international expansion.

68 Years of Heritage: A Distinctive Expression of Modern Luxury
Founded in 1958, HONGQI has spent 68 years building its automotive heritage through independent innovation, engineering excellence, and craftsmanship. Guided by a longstanding commitment to quality and safety, the brand continues to bring its distinctive heritage to a global audience.

With its Munich Advanced Design Centre, HONGQI combines global design perspectives with its rich Eastern heritage. Guided by a European Neoclassical Design Philosophy, the EHS4 brings together Eastern design influences and global aesthetics. Developed around European consumer needs, it represents HONGQI’s first model tailored specifically for Europe.

HONGQI EHS4: A New Choice for All-Electric Mobility
Bringing together Eastern and Western design aesthetics, HONGQI EHS4 balances distinctive styling, driving comfort and everyday practicality. Its Celadon Paint draws inspiration from the refined beauty of traditional Longquan celadon, while the Eyes of Infinite Allure lighting design creates a distinctive visual identity. Inside, the Crystal Control Knob adds an elegant touch to the cabin.

With a driving range of up to 470 kilometres and fast-charging capability of approximately 20 minutes, the EHS4 is designed for convenient everyday electric mobility. Its 87.4% space utilization makes intelligent use of interior space, enhancing passenger comfort and practicality.

Safety and quality remain central to its development. Equipped with seven airbags and intelligent driver-assistance technologies, the EHS4 draws on FAW’s more than 70 years of automotive manufacturing expertise to deliver advanced technology, refined driving quality, and dependable vehicle performance.

Venice: A New Chapter in Europe
On 16 November 2026, HONGQI EHS4 will make its global debut at the Scuola Grande di Santa Maria della Misericordia in Venice. The event will bring together European dealers, media representatives, and industry guests to witness an important milestone in HONGQI’s European journey.

A distinctive expression of Eastern elegance, now coming to Europe.

SOURCE HONGQI

Continue Reading

Technology

EFICYENT to Join Banks and Fintech Companies at Singapore FinTech Festival 2026

Published

8 hours ago

on

November 14, 2026

By

DUBAI, UAE, Nov. 14, 2026 /CNW/ — EFICYENT, a cross-border payment platform, is going to attend the Singapore FinTech Festival (SFF) 2026, which is going to be one of the world’s largest gatherings of the global financial and technology ecosystem.  It will take place between November 18 – 20, 2026, at Singapore. This event will converge policymakers, financial institutions, fintech companies, and investors to discuss the developments that are going to shape the future of fintech.

As financial institutions are desperately discovering new technologies, evolving payment infrastructure, and better ways to move money across borders, SFF 2026 is going to be an ideal platform for industry collaboration and knowledge exchange. The event will explore key forces transforming the financial system, including technology, geoeconomics, capital, talent, and policy, developing opportunities for businesses to engage with global industry leaders and explore emerging possibilities.

By participating in this event, EFICYENT is looking forward to connecting with other fintech companies, banks, financial institutions, and peer industry stakeholders to share their ideas, discover potential collaborations, and hold a conversation on the growing demand for efficient global payment infrastructure. Also, the company’s presence will provide an opportunity to demonstrate how its capabilities can assist businesses navigating increasingly interconnected financial markets.

Ahead of the participation, Aravinth Ramesh, CTO at EFICYENT, said:

“As financial services entered a chapter where businesses expect something beyond the ability to transfer money. They need payment platforms that offer speed, transparency, flexibility, and access to global markets. So I think events like SFF create a better opportunity to know in which direction the industry is moving, to share our perspectives with industry leaders, and explore partnerships that drive meaningful progress.”

Balasubramanyam K, CEO at EFICYENT, added:

“The future of fintech will be shaped by how effectively technology, financial institutions and payment networks work together. And this SFF event is going to remain an excellent opportunity to connect with industry leaders, better understand emerging requirements, and discover new approaches to making cross-border payments more accessible and efficient.”

About EFICYENT

EFICYENT is a global cross-border payments and financial infrastructure platform that concentrates on enabling seamless international money transfers.

They focus on simplifying international transactions and advancing digital finance. EFICYENT is committed to supporting a seamless and interconnected global payments ecosystem.

Media Contact: 
EFICYENT
Dubai, UAE
Website: https://eficyent.com/ 
Email: support@eficyent.com
LinkedIn: https://www.linkedin.com/company/eficyent/

View original content to download multimedia:https://www.prnewswire.com/news-releases/eficyent-to-join-banks-and-fintech-companies-at-singapore-fintech-festival-2026-302939546.html

SOURCE EFICYENT

Continue Reading

Trending